Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Therapy in Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00427713
What this trial is testing

Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Research UK 800
Large-scale testing (Phase 3)UnknownNCT03038217
What this trial is testing

Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant Chemoradiation
Peking Union Medical College Hospital 300
Not applicableStudy completedNCT06326619
What this trial is testing

Survival Benefit of Primary Tumour Resection Compared to Systemic Therapy Alone in Stage IV Colorectal Cancer Patients

Who this might be right for
Colorectal CancerNeoadjuvant Systemic Therapy
Medizinische Hochschule Brandenburg Theodor Fontane 480
Not applicableLooking for participantsNCT07337811
What this trial is testing

Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Who this might be right for
Rectal Cancer Patients
Sun Yat-sen University 27
Testing effectiveness (Phase 2)UnknownNCT00254683
What this trial is testing

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Who this might be right for
Rectal Cancer
University of Sao Paulo 100
Testing effectiveness (Phase 2)Study completedNCT04124601
What this trial is testing

Neoadjuvant Chemoradiotherapy With Sequential Ipilimumab and Nivolumab in Rectal Cancer

Who this might be right for
Rectal Cancer
Johannes Laengle, MD, PhD 80
Large-scale testing (Phase 3)UnknownNCT04134897
What this trial is testing

Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer

Who this might be right for
Rectal Neoplasms MalignantRectum CarcinomaRectal Cancer
Blokhin's Russian Cancer Research Center 316
Testing effectiveness (Phase 2)Looking for participantsNCT06698757
What this trial is testing

Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instability-high, Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Yugui Lian 96
Not applicableStudy completedNCT01334593
What this trial is testing

Assessment of Fitness After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

Who this might be right for
Cancer
Michelle Mossa 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT02688712
What this trial is testing

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Who this might be right for
Rectal Adenocarcinoma
Providence Health & Services 50
Large-scale testing (Phase 3)Looking for participantsNCT05984485
What this trial is testing

The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Sun Yat-sen University 766
Testing effectiveness (Phase 2)Study completedNCT00743678
What this trial is testing

Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis

Who this might be right for
Colorectal CancerUnresectable Liver Metastasis
Samsung Medical Center 73
Testing effectiveness (Phase 2)Looking for participantsNCT06002789
What this trial is testing

Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC

Who this might be right for
Multiple CancerColorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 17
Testing effectiveness (Phase 2)UnknownNCT03714490
What this trial is testing

MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer

Who this might be right for
Rectal Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Not applicableLooking for participantsNCT07638410
What this trial is testing

Prehabilitation in High-risk Oncologic Surgery

Who this might be right for
Pancreatic CancerColo-rectal CancerGastric Cancer+4 more
Fox Chase Cancer Center 180
Testing effectiveness (Phase 2)Looking for participantsNCT07277322
What this trial is testing

Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases

Who this might be right for
Metastatic Colorectal CancerLiver Metastases
Dan Feng 24
Very early researchActive Not RecruitingNCT05245786
What this trial is testing

An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaStage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8+2 more
City of Hope Medical Center 14
Large-scale testing (Phase 3)UnknownNCT06017583
What this trial is testing

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
Yong Zhang,MD 48
Testing effectiveness (Phase 2)Ended earlyNCT04177602
What this trial is testing

Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial

Who this might be right for
Locally Advanced Rectal Cancer
Universitätsklinikum Hamburg-Eppendorf 10
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Next Page